These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 16181934)

  • 41. [Subacute intensive rehabilitation after severe traumatic brain injury. Follow-up 6 months after discharge].
    Liebach A; Nordenbo AM; Engberg AW
    Ugeskr Laeger; 2007 Jan; 169(3):223-7. PubMed ID: 17234099
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of acute and chronic branched-chain amino acids on energy metabolism and muscle performance.
    De Lorenzo A; Petroni ML; Masala S; Melchiorri G; Pietrantuono M; Perriello G; Andreoli A
    Diabetes Nutr Metab; 2003; 16(5-6):291-7. PubMed ID: 15000440
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Functional plasticity or vulnerability after early brain injury?
    Anderson V; Catroppa C; Morse S; Haritou F; Rosenfeld J
    Pediatrics; 2005 Dec; 116(6):1374-82. PubMed ID: 16322161
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Effect of solutions with different amounts of branched-chain amino acids on the plasma amino acid pattern and energy metabolism of surgical intensive care patients].
    Schmitz JE; Dölp R; Grünert A; Ahnefeld FW
    Infusionsther Klin Ernahr; 1982 Apr; 9(2):100-7. PubMed ID: 6806184
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Feasibility of a skills-based substance abuse prevention program following traumatic brain injury.
    Vungkhanching M; Heinemann AW; Langley MJ; Ridgely M; Kramer KM
    J Head Trauma Rehabil; 2007; 22(3):167-76. PubMed ID: 17510592
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Placebo-controlled trial of amantadine for severe traumatic brain injury.
    Giacino JT; Whyte J; Bagiella E; Kalmar K; Childs N; Khademi A; Eifert B; Long D; Katz DI; Cho S; Yablon SA; Luther M; Hammond FM; Nordenbo A; Novak P; Mercer W; Maurer-Karattup P; Sherer M
    N Engl J Med; 2012 Mar; 366(9):819-26. PubMed ID: 22375973
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rivastigmine treatment as an add-on to antipsychotics in patients with schizophrenia and cognitive deficits.
    Chouinard S; Stip E; Poulin J; Melun JP; Godbout R; Guillem F; Cohen H
    Curr Med Res Opin; 2007 Mar; 23(3):575-83. PubMed ID: 17355738
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Occupational categories and return to work after traumatic brain injury: a multicenter study.
    Walker WC; Marwitz JH; Kreutzer JS; Hart T; Novack TA
    Arch Phys Med Rehabil; 2006 Dec; 87(12):1576-82. PubMed ID: 17141636
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of the Traumatic Brain Injury (TBI) Model Systems national dataset to a population-based cohort of TBI hospitalizations.
    Corrigan JD; Selassie AW; Lineberry LA; Millis SR; Wood KD; Pickelsimer EE; Rosenthal M
    Arch Phys Med Rehabil; 2007 Apr; 88(4):418-26. PubMed ID: 17398241
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of gender on patients with moderate to severe head injuries.
    Berry C; Ley EJ; Tillou A; Cryer G; Margulies DR; Salim A
    J Trauma; 2009 Nov; 67(5):950-3. PubMed ID: 19901653
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Branched Chain Amino Acids (BCAAs) and Traumatic Brain Injury: A Systematic Review.
    Sharma B; Lawrence DW; Hutchison MG
    J Head Trauma Rehabil; 2018; 33(1):33-45. PubMed ID: 28060208
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Recovery of cognitive function after traumatic brain injury: a multilevel modeling analysis of Canadian outcomes.
    Christensen BK; Colella B; Inness E; Hebert D; Monette G; Bayley M; Green RE
    Arch Phys Med Rehabil; 2008 Dec; 89(12 Suppl):S3-15. PubMed ID: 19081439
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Demographics, injury characteristics and outcome of traumatic brain injuries in northern Sweden.
    Jacobsson LJ; Westerberg M; Lexell J
    Acta Neurol Scand; 2007 Nov; 116(5):300-6. PubMed ID: 17922723
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The presence of the adult respiratory distress syndrome does not worsen mortality or discharge disability in blunt trauma patients with severe traumatic brain injury.
    Salim A; Martin M; Brown C; Inaba K; Browder T; Rhee P; Teixeira PG; Demetriades D
    Injury; 2008 Jan; 39(1):30-5. PubMed ID: 17920066
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anorexia and plasma levels of free tryptophan, branched chain amino acids, and ghrelin in hemodialysis patients.
    Bossola M; Scribano D; Colacicco L; Tavazzi B; Giungi S; Zuppi C; Luciani G; Tazza L
    J Ren Nutr; 2009 May; 19(3):248-55. PubMed ID: 19243975
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Branched-chain amino acid-enriched supplementation improves insulin resistance in patients with chronic liver disease.
    Kawaguchi T; Nagao Y; Matsuoka H; Ide T; Sata M
    Int J Mol Med; 2008 Jul; 22(1):105-12. PubMed ID: 18575782
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Human mild traumatic brain injury decreases circulating branched-chain amino acids and their metabolite levels.
    Jeter CB; Hergenroeder GW; Ward NH; Moore AN; Dash PK
    J Neurotrauma; 2013 Apr; 30(8):671-9. PubMed ID: 23560894
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reduced plasma levels of tyrosine, precursor of brain catecholamines, and of essential amino acids in patients with severe traumatic brain injury after rehabilitation.
    Aquilani R; Iadarola P; Boschi F; Pistarini C; Arcidiaco P; Contardi A
    Arch Phys Med Rehabil; 2003 Sep; 84(9):1258-65. PubMed ID: 13680559
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oral branched-chain amino acid supplements that reduce brain serotonin during exercise in rats also lower brain catecholamines.
    Choi S; Disilvio B; Fernstrom MH; Fernstrom JD
    Amino Acids; 2013 Nov; 45(5):1133-42. PubMed ID: 23904096
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A dose-finding study on the effects of branch chain amino acids on surrogate markers of brain dopamine function.
    Gijsman HJ; Scarnà A; Harmer CJ; McTavish SB; Odontiadis J; Cowen PJ; Goodwin GM
    Psychopharmacology (Berl); 2002 Mar; 160(2):192-7. PubMed ID: 11875637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.